Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2009;105:431-441
Published online before print July 23, 2009, doi: 10.1161/CIRCRESAHA.109.203083
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
105/5/431    most recent
CIRCRESAHA.109.203083v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by van Wijk, B.
Right arrow Articles by van den Hoff, M. J.B.
PubMed
Right arrow PubMed Citation
Right arrow Articles by van Wijk, B.
Right arrow Articles by van den Hoff, M. J.B.
Related Collections
Right arrow Cardiac development
Right arrowRelated Article
(Circulation Research. 2009;105:431.)
© 2009 American Heart Association, Inc.


Molecular Medicine

Epicardium and Myocardium Separate From a Common Precursor Pool by Crosstalk Between Bone Morphogenetic Protein– and Fibroblast Growth Factor–Signaling Pathways

Bram van Wijk, Gert van den Berg, Radwan Abu-Issa, Phil Barnett, Saskia van der Velden, Martina Schmidt, Jan M. Ruijter, Margaret L. Kirby, Antoon F.M. Moorman, Maurice J.B. van den Hoff

From the Heart Failure Research Center (B.v.W., G.v.d.B., P.B., S.v.d.V., M.S., J.M.R., A.F.M.M., M.J.B.v.d.H.) and Department of Pharmacology and Pharmacotherapy (M.S.), Academic Medical Center, Amsterdam, The Netherlands; Department of Biology (R.A.-I.), University of Michigan, Dearborn; Department of Molecular Pharmacology (M.S.), University of Groningen, The Netherlands; and Department of Pediatrics (M.L.K.), Neonatal-Perinatal Research Institute, Duke University Medical Center, Durham, NC.

Correspondence to Maurice J.B. van den Hoff, PhD, Academic Medical Center, Department Anatomy and Embryology, Meibergdreef 15, 1105AZ Amsterdam, The Netherlands. E-mail m.j.vandenhoff{at}amc.uva.nl

Rationale: The epicardium contributes to the majority of nonmyocardial cells in the adult heart. Recent studies have reported that the epicardium is derived from Nkx2.5-positive progenitors and can differentiate into cardiomyocytes. Not much is known about the relation between the myocardial and epicardial lineage during development, whereas insights into these embryonic mechanisms could facilitate the design of future regenerative strategies.

Objective: Acquiring insight into the signaling pathways involved in the lineage separation leading to the differentiation of myocardial and (pro)epicardial cells at the inflow of the developing heart.

Methods and Results: We made 3D reconstructions of Tbx18 gene expression patterns to give insight into the developing epicardium in relation to the developing myocardium. Next, using DiI tracing, we show that the (pro)epicardium separates from the same precursor pool as the inflow myocardium. In vitro, we show that this lineage separation is regulated by a crosstalk between bone morphogenetic protein (BMP) signaling and fibroblast growth factor (FGF) signaling. BMP signaling via Smad drives differentiation toward the myocardial lineage, which is inhibited by FGF signaling via mitogen-activated protein kinase kinase (Mek)1/2. Embryos exposed to recombinant FGF2 in vivo show enhanced epicardium formation, whereas a misbalance between FGF and BMP by Mek1/2 inhibition and BMP stimulation causes a developmental arrest of the epicardium and enhances myocardium formation at the inflow of the heart.

Conclusion: Our data show that FGF signaling via Mek1/2 is dominant over BMP signaling via Smad and is required to separate the epicardial lineage from precardiac mesoderm. Consequently, myocardial differentiation requires BMP signaling via Smad and inhibition of FGF signaling at the level of Mek1/2. These findings are of clinical interest for the development of regeneration-based therapies for heart disease.


Key Words: cardiovascular development • proepicardium • epicardium • BMP • FGF • regeneration


Related Article:

Look Who’s Talking: FGFs and BMPs in the Proepicardium
Eric C. Svensson
Circ. Res. 2009 105: 406-407. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
Circ. Res.Home page
E. C. Svensson
Look Who's Talking: FGFs and BMPs in the Proepicardium
Circ. Res., August 28, 2009; 105(5): 406 - 407.
[Full Text] [PDF]